14

D.E. Mandelbaum: drafting/revising the manuscript, data acquisition, study concept or design, analysis or interpretation of data, accepts responsibility for conduct of research and final approval, acquisition of data, writing of paper. J. Mink: drafting/revising the manuscript, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. M. Mintz: drafting/revising the manuscript, data acquisition, study concept or design, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. A. Tilton: drafting/revising the manuscript, data acquisition, study concept or design, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. W. Trescher: drafting/revising the manuscript, data acquisition, analysis or interpretation of data, accepts responsibility for conduct of research and final approval, acquisition of data, study supervision. Study funding No targeted funding reported. Disclosure M.L. Zupanc has research support for an investigatorinitiated retrospective study on infantile spasms from Mallinckrodt and clinical research support for investigational drug study from Zogenix, both paid to her employer; is on the Speaker’s Bureau for Mallinckrodt, Eisai Inc., Aquestive Therapeutics, and Greenwich Pharmaceuticals, and has received honoraria; and is on the editorial board for Pediatric Neurology. B.H. Cohen receives research support from Stealth Biotherapeutics, BioElectron Technologies, Reath Pharmaceuticals, and Horizon Pharmaceuticals, all paid to his employer; is a consultant for Stealth Biotherapeutics and Modis Pharmaceuticals; is an educational speaker and CPT Advisor for the AAN; and has received honoraria for his services. P.B. Kang is a consultant for AveXis for a clinical trial and a consultant for ChromaDex; is on the advisory board for Sarepta Therapeutics; and is a coeditor for Muscle and Nerve, coeditor for Pediatric EMG (textbook), and author for UpToDate. D.E. Mandelbaum is on the Scientific Advisory Board of Teva Pharmaceuticals; is on the editorial boards of Pediatric Neurologyand Journal of Child Neurology; occasionally performs medical expert consultations; and performs locum tenens (CompHealth). J. Mink has received research support from Abeona Inc. and Beyond Batten Disease Foundation; has research funding from the NIH and has received institutional support from the University of Rochester for research; serves as Associate Editor of Neurology and Associate Editor of Continuum; receives royalties from Elsevier, Inc.; and serves as a consultant for Abide Inc., Censa Inc., TEVA Inc., Bluebird Bio, and Neurogene. M. Mintz has functioned as principal investigator for clinical trials research contracted through the Clinical Research Center of New Jersey (CRCN) sponsored by the following companies: Aquestive Therapeutics, Curemark, Eisai Inc., Impax Laboratories, Neurim Pharmaceuticals, Nuvelution Pharma Inc., PhenoSolve, Sunovion, and Teva; is a consultant to Philips-Electrical Geodesics contracted through the Center for Neurologic and Neurodevelopmental Health (CNNH) and is on the scientific advisory board of NeuroNeeds; serves on the editorial boards of the Journal of Child Neurology and Vision Development and Rehabilitation; has functioned as an expert witness in various litigation and mitigation cases, contracted through CNNH NeuroHealth; and is the Chief Medical Officer, Owner, and Founder of CNNH and CRCN, a board member of CNNH Management, Inc., and is President and Founder of NeurAbilities, a 501(3)c public charity. A. Tilton has worked with Ipsen Pharmaceutical on the development of a clinical study protocol and is a study investigator, with research support; is a consultant and educator for Eisai, Inc. and has received honoraria; and is a speaker on transitions of care for the Child Neurology Foundation. W. Trescher is an editor for the Journal of Pediatric Neurology. Go to Neurology.org/N for full disclosures. Publication history Received by Neurology March 20, 2019. Accepted in final form October 29, 2019. References 1. Talbot SG, Dean W. STAT: Physicians Aren’t “Burning Out”: They’re Suffering from Moral Injury. 2018. Available at: www.statnews.com/2018/07/26/physicians-notburning-out. Accessed August 2019. 2. American Academy of Neurology Compensation and Productivity Report: 2016 Report on 2015 Data. Minneapolis: American Academy of Neurology; 2016. 3. Sullivan Cotter 2018 Survey: Pediatric Neurology. Available at: https://sullivancotter. com. Accessed August 2019. 4. ECG 2018 National Pediatric Subspecialty Survey: Pediatric Neurology. Available at: www.ecg.com. Accessed August 2019. 5. Kang PB, Bale JF, Mintz M, et al. The child neurology clinical workforce in 2015: report of the AAP/CHS Joint Taskforce. Neurology 2016;87:1284–1392. 6. Busis NA, Tait DS, Levin KH, et al. Burnout, career satisfaction, and well-being among US neurologists in 2016. Neurology 2017;88:1–12. 7. Zupanc ML, Tran LH, Mower A, et al. Cost effectiveness of multidisciplinary team approach in intractable epilepsy patients [abstract]. Presented at the 2015 meeting of the American Epilepsy Society; Philadelphia; 2015. 8. Wagner JL, Levisohn PM, Onufer CN, et al. Project access: strategies to improve care for children and youth with epilepsy: illustrations of recommendations in the IOM report on epilepsies.